Early test: can new drugs prime immune system to attack prostate cancer before surgery?
NCT ID NCT06888102
Summary
This early study is testing whether giving epigenetic drugs for a few weeks before prostate removal surgery is safe and can make the tumor more visible to the patient's own immune system. It will involve about 20 men with high-risk prostate cancer who are already scheduled for surgery. The main goal is to check safety and see if the drugs cause measurable biological changes in the tumor tissue, not to cure the cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Cedars-Sinai Cancer at SOCC
RECRUITINGLos Angeles, California, 90048, United States
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Contact
Conditions
Explore the condition pages connected to this study.